Screener
Halozyme Therapeutics HALO Gross Profit
Gross Profit at other companies
Other financials
Where this comes from
Calculated from Halozyme Therapeutics’s reported figures.
The source filing: Halozyme Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001159036-26-000104
FAQ
- What is Halozyme Therapeutics's gross profit?
- Halozyme Therapeutics (HALO) reported gross profit of $401.83M in Q2 2026.
- How has Halozyme Therapeutics's gross profit changed year-over-year?
- Halozyme Therapeutics's gross profit increased by 43.8% year-over-year, from $279.36M to $401.83M.
- What is the long-term trend for Halozyme Therapeutics's gross profit?
- Over 4 years (2021 to 2025), Halozyme Therapeutics's gross profit has grown at a 34.0% compound annual growth rate (CAGR), from $361.9M to $1.17B.
- What does gross profit mean?
- Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.
Ask your AI about Halozyme Therapeutics's gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude